Azitra, Inc. (AZTR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Azitra, Inc. (AZTR) stock price & volume — 10-year historical chart
Azitra, Inc. (AZTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Azitra, Inc. (AZTR) competitors in Microbiome and Phage Therapeutics — business model, growth, and fundamentals comparison
Azitra, Inc. (AZTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Azitra, Inc. (AZTR) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|
| Sales/Revenue | 110K | 284K | 686K | 7.5M | 0 |
| Revenue Growth % | - | 158.18% | 141.55% | 993.29% | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 453.14K |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | 110K▲ 0% | 284K▲ 158.2% | 686K▲ 141.5% | 7.5M▲ 993.3% | -453.14K▼ 106.0% |
| Gross Margin % | 100% | 100% | 100% | 100% | - |
| Gross Profit Growth % | - | 158.18% | 141.55% | 993.29% | -106.04% |
| Operating Expenses | 9.33M | 9.74M | 8.14M | 10.99B | 10.51M |
| OpEx % of Revenue | 8483.14% | 3428.73% | 1186.09% | 146568.53% | - |
| Selling, General & Admin | 3.95M | 3.64M | 4.49M | 6.27B | 6.13B |
| SG&A % of Revenue | 3592.14% | 1281.57% | 655% | 83590.16% | - |
| Research & Development | 5.38M | 6.1M | 3.64M | 4.72B | 4.84B |
| R&D % of Revenue | 4891% | 2147.16% | 531.08% | 62978.37% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -10.96B |
| Operating Income | -9.22M▲ 0% | -9.45M▼ 2.5% | -7.45M▲ 21.2% | -10.99B▼ 147340.7% | -10.97M▲ 99.9% |
| Operating Margin % | -8383.14% | -3328.73% | -1086.09% | -146468.53% | - |
| Operating Income Growth % | - | -2.52% | 21.19% | -147340.74% | 99.9% |
| EBITDA | -9.14M | -9.05M | -7.02M | -10.98B | -10.51M |
| EBITDA Margin % | -8306.07% | -3185.78% | -1024.05% | -146462.56% | - |
| EBITDA Growth % | - | 0.97% | 22.36% | -156265.79% | 99.9% |
| D&A (Non-Cash Add-back) | 84.77K | 405.98K | 425.55K | 448.24K | 453.14K |
| EBIT | -8.87M | -10.43M | -11.1M | -8.95M | -10.94M |
| Net Interest Income | -58.21K | -247.07K | -166.15K | 110.39K | 62.62K |
| Interest Income | 8.76K | 4.82K | 1.58K | 122.55K | 70.21K |
| Interest Expense | 66.97K | 251.89K | 167.73K | 12.16K | 7.59K |
| Other Income/Expense | 281.78K | -1.23M | -3.82M | 10.98B | 19.61K |
| Pretax Income | -8.94M▲ 0% | -10.68M▼ 19.5% | -11.27M▼ 5.5% | -8.96M▲ 20.5% | -10.95M▼ 22.2% |
| Pretax Margin % | -8126.98% | -3760.69% | -1642.34% | -119.45% | - |
| Income Tax | 0 | 0 | 17.31K | 9.03K | 8.32K |
| Effective Tax Rate % | 0% | 0% | -0.15% | -0.1% | -0.08% |
| Net Income | -8.94M▲ 0% | -10.68M▼ 19.5% | -11.28M▼ 5.6% | -8.97M▲ 20.5% | -10.96M▼ 22.2% |
| Net Margin % | -8126.98% | -3760.69% | -1644.87% | -119.57% | - |
| Net Income Growth % | - | -19.47% | -5.65% | 20.53% | -22.17% |
| Net Income (Continuing) | -8.94M | -10.68M | -11.28M | -8.97M | -10.96M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.33▲ 0% | -3.98▼ 19.5% | -4.20▼ 5.5% | -0.36▲ 91.5% | -2.25▼ 532.2% |
| EPS Growth % | - | -19.47% | -5.55% | 91.53% | -532.28% |
| EPS (Basic) | -3.33 | -3.98 | -7.34 | -0.36 | -2.25 |
| Diluted Shares Outstanding | 60.49K | 60.49K | 34.51K | 567.57K | 4.87M |
| Basic Shares Outstanding | 60.49K | 60.49K | 34.51K | 567.57K | 4.87M |
| Dividend Payout Ratio | - | - | - | - | - |
Azitra, Inc. (AZTR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|
| Total Current Assets | 8.49M | 4.14M | 2.54M | 5.23M | 3.02B |
| Cash & Short-Term Investments | 8.04M | 3.49M | 1.8M | 4.55M | 2.07B |
| Cash Only | 8.04M | 3.49M | 1.8M | 4.55M | 2.07B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 334.18K | 266.21K | 223.47K | 101.9K | 141.29K |
| Days Sales Outstanding | 1.11K | 342.13 | 118.9 | 4.96 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 0 | 216.89K | 67.86K | 4.11K | 950.29M |
| Total Non-Current Assets | 1.71M | 3.03M | 2.58M | 2.13M | 2.01B |
| Property, Plant & Equipment | 946.68K | 1.96M | 1.58M | 1.21M | 962.08M |
| Fixed Asset Turnover | 0.12x | 0.14x | 0.43x | 6.22x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 97.69K | 219.57K | 210.88K | 246.42K | 316.67M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 668.23K | 848.34K | 789.99K | 678.22K | 727.31M |
| Total Assets | 10.2M▲ 0% | 7.17M▼ 29.7% | 5.12M▼ 28.6% | 7.36M▲ 43.9% | 5.03B▲ 68190.8% |
| Asset Turnover | 0.01x | 0.04x | 0.13x | 1.02x | - |
| Asset Growth % | - | -29.74% | -28.63% | 43.85% | 68190.82% |
| Total Current Liabilities | 1.21M | 2.22M | 1.6M | 1.38M | 1.07B |
| Accounts Payable | 717.8K | 784.69K | 897.27K | 490.25K | 399.36K |
| Days Payables Outstanding | - | - | - | - | 321.67 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 265.89M |
| Deferred Revenue (Current) | 15K | 156K | 0 | 0 | 0 |
| Other Current Liabilities | 43.47K | 27.08K | 145.04K | 32.97K | 801.67M |
| Current Ratio | 7.02x | 1.86x | 1.58x | 3.80x | 2.83x |
| Quick Ratio | 7.02x | 1.86x | 1.58x | 3.80x | 2.83x |
| Cash Conversion Cycle | - | - | - | - | - |
| Total Non-Current Liabilities | 34.76M | 41.21M | 599.14K | 284.65K | 156.19M |
| Long-Term Debt | 992.02K | 6.6M | 0 | 0 | 156.19M |
| Capital Lease Obligations | 0 | 840.9K | 563.69K | 284.27K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 33.77M | 33.76M | 35.45K | 381 | -156.19K |
| Total Liabilities | 35.97M | 43.43M | 2.2M | 1.66M | 1.22B |
| Total Debt | 992.02K | 7.73M | 885.95K | 555.51K | 422.08M |
| Net Debt | -7.05M | 4.24M | -910.04K | -4M | -1.65B |
| Debt / Equity | - | - | 0.30x | 0.10x | 0.11x |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | -137.70x | -37.53x | -44.42x | -903383.22x | -1445.45x |
| Total Equity | -25.77M▲ 0% | -36.26M▼ 40.7% | 2.91M▲ 108.0% | 5.7M▲ 95.6% | 3.8B▲ 66608.2% |
| Equity Growth % | - | -40.73% | 108.03% | 95.61% | 66608.16% |
| Book Value per Share | -425.93 | -599.41 | 84.40 | 10.04 | 779.97 |
| Total Shareholders' Equity | -25.77M | -36.26M | 2.91M | 5.7M | 3.8B |
| Common Stock | 104 | 104 | 1.21K | 763 | 1.07K |
| Retained Earnings | -26.63M | -37.31M | -48.6M | -57.57M | -68.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
Azitra, Inc. (AZTR) cash flow — operating, investing & free cash flow history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|
| Cash from Operations | -8.07M | -8.35M | -7.36M | -10.18M | -11.22M |
| Operating CF Margin % | -7333.96% | -2939.95% | -1073.23% | -135.78% | - |
| Operating CF Growth % | - | -3.5% | 11.82% | -38.32% | -10.22% |
| Net Income | -8.94M | -10.68M | -11.28M | -8.97M | -10.96B |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K | 453.14M |
| Stock-Based Compensation | 306.06K | 184.47K | 151.5K | 245.05K | 62.74M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -164.86K | 1.43M | 4.1M | -1.47M | 10.43B |
| Working Capital Changes | 646.35K | 310.76K | -753.43K | -441.72K | -797.23K |
| Change in Receivables | 194.17K | 66.67K | 42.73K | 133.15K | -44.72K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 282.98K | 420.75K | -68.68K | -140.53K | -500.32K |
| Cash from Investing | -652.27K | -336.76K | -318.26K | -379.25K | -182.91K |
| Capital Expenditures | -446.14K | -33.1K | -26.54K | -8.57K | -24.21M |
| CapEx % of Revenue | 405.58% | 11.66% | 3.87% | 0.11% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | -206.14K | -303.66K | -291.71K | -370.68K | 24.03M |
| Cash from Financing | 992.86K | 4.13M | 5.98M | 13.32M | 8.92M |
| Debt Issued (Net) | 984.39K | 4.35M | -7.39K | -14.6K | -112.64K |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 8.47K | -215.38K | 0 | -18.38K | 0 |
| Net Change in Cash | -7.73M▲ 0% | -4.55M▲ 41.1% | -1.7M▲ 62.7% | 2.76M▲ 262.6% | -2.49M▼ 190.1% |
| Free Cash Flow | -8.72M▲ 0% | -8.69M▲ 0.3% | -7.68M▲ 11.6% | -10.56M▼ 37.5% | -11.25B▼ 106388.2% |
| FCF Margin % | -7926.94% | -3060.03% | -1119.63% | -140.84% | - |
| FCF Growth % | - | 0.33% | 11.62% | -37.53% | -106388.24% |
| FCF per Share | -144.14 | -143.66 | -222.53 | -18.61 | -2308.04 |
| FCF Conversion (FCF/Net Income) | 0.90x | 0.78x | 0.65x | 1.14x | 1.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Azitra, Inc. (AZTR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -387.34% | -208.27% | -0.58% |
| Return on Invested Capital (ROIC) | - | - | -278.96% | -445079.83% | -0.76% |
| Gross Margin | 100% | 100% | 100% | 100% | - |
| Net Margin | -8126.98% | -3760.69% | -1644.87% | -119.57% | - |
| Debt / Equity | - | - | 0.30x | 0.10x | 0.11x |
| Interest Coverage | -137.70x | -37.53x | -44.42x | -903383.22x | -1445.45x |
| FCF Conversion | 0.90x | 0.78x | 0.65x | 1.14x | 1.02x |
| Revenue Growth | - | 158.18% | 141.55% | 993.29% | -100% |
Azitra, Inc. (AZTR) stock FAQ — growth, dividends, profitability & financials explained
Azitra, Inc. (AZTR) saw revenue decline by 100.0% over the past year.
Azitra, Inc. (AZTR) reported a net loss of $11.0M for fiscal year 2025.
Azitra, Inc. (AZTR) has a return on equity (ROE) of -0.6%. Negative ROE indicates the company is unprofitable.
Azitra, Inc. (AZTR) had negative free cash flow of $86.5M in fiscal year 2025, likely due to heavy capital investments.
Azitra, Inc. (AZTR) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates